Skip to main content

Advertisement

Log in

Increased expression of ESCO1 is correlated with poor patient survival and its role in human bladder cancer

  • Original Article
  • Published:
Tumor Biology

Abstract

There is increasing evidence suggesting that establishment of sister chromatid cohesion N-acetyltransferase 1 (ESCO1) was involved in tumorigenesis. However, its role in bladder cancer remains unclear. In this study, we aimed to study the clinical correlation and biological significance of ESCO1 in bladder cancer. Our results showed that ESCO1 was significantly over-expressed in bladder cancer tissues compared with that in adjacent normal tissues. And, increased ESCO1 expression was significantly associated with higher grade (P < 0.001), higher tumor stage (P = 0.014), and multifocality (P = 0.042). Kaplan–Meier analysis and Cox proportional hazards model were performed to determine the prognostic significance of ESCO1, and the results showed that ESCO1 is a useful prognostic marker for bladder cancer patients. Moreover, we found that ESCO1 knockdown inhibited the growth, migration, and invasion of bladder cancer cells. In conclusion, our findings indicated that ESCO1 may play an important role in human bladder cancer, and ESCO1 might serve as a novel target and prognosis factor for human bladder cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29. doi:10.3322/caac.21208.

    Article  PubMed  Google Scholar 

  2. Yang GL, Zhang LH, Bo JJ, Huo XJ, Chen HG, Cao M, et al. Increased expression of HMGB1 is associated with poor prognosis in human bladder cancer. J Surg Oncol. 2012;106(1):57–61. doi:10.1002/jso.23040.

    Article  CAS  PubMed  Google Scholar 

  3. Herr HW, Faulkner JR, Grossman HB, Natale RB, deVere White R, Sarosdy MF, et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol. 2004;22(14):2781–9. doi:10.1200/JCO.2004.11.024.

    Article  PubMed  Google Scholar 

  4. Herr HW, Dotan Z, Donat SM, Bajorin DF. Defining optimal therapy for muscle invasive bladder cancer. J Urol. 2007;177(2):437–43. doi:10.1016/j.juro.2006.09.027.

    Article  CAS  PubMed  Google Scholar 

  5. Zhang J, Shi X, Li Y, Kim BJ, Jia J, Huang Z, et al. Acetylation of Smc3 by Eco1 is required for S phase sister chromatid cohesion in both human and yeast. Mol Cell. 2008;31(1):143–51. doi:10.1016/j.molcel.2008.06.006.

    Article  CAS  PubMed  Google Scholar 

  6. Unal E, Heidinger-Pauli JM, Koshland D. DNA double-strand breaks trigger genome-wide sister-chromatid cohesion through Eco1 (Ctf7). Science. 2007;317(5835):245–8. doi:10.1126/science.1140637.

    Article  PubMed  Google Scholar 

  7. Barber TD, McManus K, Yuen KW, Reis M, Parmigiani G, Shen D, et al. Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proc Natl Acad Sci U S A. 2008;105(9):3443–8. doi:10.1073/pnas.0712384105.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Price JC, Pollock LM, Rudd ML, Fogoros SK, Mohamed H, Hanigan CL, et al. Sequencing of candidate chromosome instability genes in endometrial cancers reveals somatic mutations in ESCO1, CHTF18, and MRE11A. PLoS One. 2014;8(6):e63313. doi:10.1371/journal.pone.0063313.

    Article  PubMed  Google Scholar 

  9. Luedeke M, Linnert CM, Hofer MD, Surowy HM, Rinckleb AE, Hoegel J, et al. Predisposition for TMPRSS2-ERG fusion in prostate cancer by variants in DNA repair genes. Cancer Epidemiol Biomark Prev. 2009;18(11):3030–5. doi:10.1158/1055-9965.EPI-09-0772.

    Article  CAS  Google Scholar 

  10. Lei Y, Yan S, Ming-De L, Na L, Rui-Fa H. Prognostic significance of Aurora-A expression in human bladder cancer. Acta Histochem. 2011;113(5):514–8. doi:10.1016/j.acthis.2010.05.004.

    Article  PubMed  Google Scholar 

  11. Naito S, Bilim V, Yuuki K, Ugolkov A, Motoyama T, Nagaoka A, et al. Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer. Clin Cancer Res. 2010;16(21):5124–32. doi:10.1158/1078-0432.CCR-10-0275.

    Article  CAS  PubMed  Google Scholar 

  12. Wu CF, Ng KF, Chen CS, Chang PL, Chuang CK, Weng WH, et al. Expression of parvin-beta is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract. Br J Cancer. 2010;103(6):852–60. doi:10.1038/sj.bjc.6605835.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Kwak C, Lee SE, Jeong IG, Ku JH. Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract. Urology. 2006;68(1):53–7. doi:10.1016/j.urology.2006.01.053.

    Article  PubMed  Google Scholar 

  14. Mhawech-Fauceglia P, Cheney RT, Schwaller J. Genetic alterations in urothelial bladder carcinoma: an updated review. Cancer. 2006;106(6):1205–16. doi:10.1002/cncr.21743.

    Article  CAS  PubMed  Google Scholar 

  15. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, et al. Mutations of mitotic checkpoint genes in human cancers. Nature. 1998;392(6673):300–3. doi:10.1038/32688.

    Article  CAS  PubMed  Google Scholar 

  16. Rajagopalan H, Jallepalli PV, Rago C, Velculescu VE, Kinzler KW, Vogelstein B, et al. Inactivation of hCDC4 can cause chromosomal instability. Nature. 2004;428(6978):77–81. doi:10.1038/nature02313.

    Article  CAS  PubMed  Google Scholar 

  17. Wang Z, Cummins JM, Shen D, Cahill DP, Jallepalli PV, Wang TL, et al. Three classes of genes mutated in colorectal cancers with chromosomal instability. Cancer Res. 2004;64(9):2998–3001.

    Article  CAS  PubMed  Google Scholar 

  18. Solomon DA, Kim T, Diaz-Martinez LA, Fair J, Elkahloun AG, Harris BT, et al. Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science. 2011;333(6045):1039–43. doi:10.1126/science.1203619.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Welch JS, Ley TJ, Link DC, Miller CA, Larson DE, Koboldt DC, et al. The origin and evolution of mutations in acute myeloid leukemia. Cell. 2012;150(2):264–78. doi:10.1016/j.cell.2012.06.023.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Rocquain J, Gelsi-Boyer V, Adelaide J, Murati A, Carbuccia N, Vey N, et al. Alteration of cohesin genes in myeloid diseases. Am J Hematol. 2010;85(9):717–9. doi:10.1002/ajh.21798.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank all patients and people who had participated in this research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Heqing Guo.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

Conflicts of interest

None

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, S., Li, J., Zhou, G. et al. Increased expression of ESCO1 is correlated with poor patient survival and its role in human bladder cancer. Tumor Biol. 37, 5165–5170 (2016). https://doi.org/10.1007/s13277-015-4375-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-4375-1

Keywords

Navigation